References
- Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002;126:1304–18.
- Belinda C, Gavin S, Lesley R. Recurrent miscarriage: pathophysiology and outcome. Obstet Gynacol 2005;17:591–7.
- Kovalevsky G, Gracia CR, Jesse A, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. A meta-analysis. Arch Intern Med 2004;164:558–63.
- Rosendorff A, Dorfman DM. Activated protein c resistance and factor V Leiden: a review. Arch Pathol Lab Med 2007;131:866–71.
- Dahlback B. Procoagulant and anticoagulant properties of coagulation factor V. Factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms. J Lab Clin Med 1999;133:415–22.
- Nicolaes GA, Dahlback B. Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 2002;22:530–8.
- Dahlback B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 2005;257:209–23.
- Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001;45:65–71.
- Rai R, Tuddenham E, Backos M, Jivraj S, El’Gaddal S, Choy S, et al.. Thromboelastography, whole blood haemostasis and recurrent miscarriage. Hum Reprod 2003;18:2540–3.
- Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al.. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374–80.
- Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004;191:412–24.
- Serour G, Younis N, Hefnawi F, Daghistani H, El-bahy M, Nawara M, et al.. Pregnancy wastage. Popul Sci 1981;(2):57–69.
- Ripoll L, Paulin D, Thomas S, Drouet LO. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene. Thromb Haemost 1997;78:960–1.
- Hezard N, Cornillet L, Lefebvre P, Gillot L, Potron G, Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene G-A20210 Prothrombin gene and C-T677 MTHFR gene mutations. Thromb Haemost 1998;79:1054–5.
- Krause M, Zwinge B, Vigh TH, Scharrer I. Important role of FV G1691A in women with pregnancy loss without apparent causes. J Thromb Haemost 2003;1:12–8.
- Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost 2005;3:1603–10.
- Ulu A, Elsobky E, Elsayed M, Yidiz Z, Tekin M, Akar N. Frequency of five thrombophilic polymorphisms in the Egyptian population. Turk J Hematol 2006;23:100–3.
- Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms in women with fetal loss. Thromb Haemost 1999;82:6–9.
- Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, et al.. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C6777T, are associated with recurrent miscarriages. Hum Reprod 2000;15:458–62.
- Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T, et al.. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case–control study. Thromb Haemost 2006;95:612–7.
- Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, et al.. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 2005;119:164–70.
- Grandone E, Margaglione M, Colaizzo D, d’Addedda M, Cappucci G, Vecchione G, et al.. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822–4.
- Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al.. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the Mediterranean population. Arch Gynecol Obstet 2005;273:170–3.
- Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002;17:1633–37.
- Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, et al.. Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thromb Res 2006;117:681–4.
- Sotiriadis A, Vartholomatos G, Pavlou M, Kolaitis N, Dova L, Stefos T, et al.. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol 2007;57:133–41.
- Mougiou A, Androutsopoulos G, Karakantza M, Theodori E, Decavalas G, Zoumbos N. Inherited thrombophilia screening in Greek women with recurrent fetal loss. Clin Exp Obstet Gynecol 2008;35:172–4.
- Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al.. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol 2007;86:727–31.
- Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901–8.
- Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R. Genetic thrombophilic defects (factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss. Akush Ginekol (Sofiia) 2007;46:10–6.
- Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al.. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015–8.
- Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U, et al.. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001;46:124–31.